The Merkel Cell Carcinoma (MCC) Patient Registry initiative organized by Project Data Sphere is off to a fast start in 2022 with four manuscripts accepted for publication.
Home
Convener, collaborator, catalyst in the fight against cancer.
At Project Data Sphere®, we believe in breaking down barriers to cancer clinical trial data sharing — barriers that historically have kept valuable trial data from ultimately benefitting the patients who so selflessly participate in them. By aggregating trial data from biopharmaceutical companies, academic medical centers, and government organizations and making it freely available on our open-access platform, we have established ourselves as a premier resource for the global oncology research community. Our deep relationships with renowned oncology experts allow us to convene research collaborations that leverage the power of pooled clinical trial data and which ultimately position PDS to be a catalyst for the discovery of urgently needed new treatments while helping to make cancer trials faster, more effective, and less expensive.
Data Providers



















Sponsored Research
Latest News

Project Data Sphere’s Images & Algorithms (I&A) Program presented preliminary results from its autoRECIST project at the FDA Research Grand Rounds on Feb. 25. Nearly 200 attendees participated in this webinar which generated a great discussion.